The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.
about
Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmissionSerotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorderIncreased Serotonin Transporter Expression Reduces Fear and Recruitment of Parvalbumin Interneurons of the Amygdala.Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J miceSerotonergic hallucinogens as translational models relevant to schizophrenia.Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use.Postnatal serotonin type 2 receptor blockade prevents the emergence of anxiety behavior, dysregulated stress-induced immediate early gene responses, and specific transcriptional changes that arise following early life stress.Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors--a new analysis of data from the archives and implications for improved antimanic treatments.Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeysEffects of serotonin (5-HT)1A and 5-HT2A receptor agonists on schedule-controlled responding in rats: drug combination studies.ITI-007 demonstrates brain occupancy at serotonin 5-HT₂A and dopamine D₂ receptors and serotonin transporters using positron emission tomography in healthy volunteers.Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model.Serotonin (5-hydroxytryptamine) 5-HT(2A) receptor: association with inherent and cocaine-evoked behavioral disinhibition in rats.Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the ratActivation of adenosine₁ receptors induces antidepressant-like, anti-impulsive effects on differential reinforcement of low-rate 72-s behavior in ratsTypical and atypical antipsychotic drugs increase extracellular histamine levels in the rat medial prefrontal cortex: contribution of histamine h(1) receptor blockadeThe role of serotonin receptor subtypes in treating depression: a review of animal studiesAssociation Study of Genotype by Depressive Response during Tryptophan Depletion in Subjects Recovered from Major Depression5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in ratsRegulation of rat cortical 5-hydroxytryptamine2A receptor-mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine.Prefrontal/amygdalar system determines stress coping behavior through 5-HT/GABA connection.Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout modelsComparison of female Fischer and Sprague-Dawley rats in the response to ketanserin.Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition.5-HT2 ligands in the treatment of anxiety and depression.The Utility of Impulsive Bias and Altered Decision Making as Predictors of Drug Efficacy and Target Selection: Rethinking Behavioral Screening for Antidepressant Drugs.Preclinical findings predicting efficacy and side-effect profile of LY2940094, an antagonist of nociceptin receptors.Premature responses in the five-choice serial reaction time task reflect rodents' temporal strategies: evidence from no-light and pharmacological challenges.Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models.Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice.Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administration.5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system.Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons.Effects of Kaixin Jieyu Decoction () on behavior, monoamine neurotransmitter levels, and serotonin receptor subtype expression in the brain of a rat depression model.Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice.
P2860
Q23913269-BF30A240-C701-47BF-92B0-7B92EEF56237Q27015917-B3088DE9-23A5-46AF-931E-CDD89C537B43Q27310831-29BD5D79-A1A0-48F6-8E27-2E9223055247Q28397643-91CC3325-C739-4EFE-BF72-6557D51E07C6Q30427074-6A74F55A-881A-4540-8AA7-7CBB0028E37FQ30453028-8C6DD5EF-293A-459C-9183-23E48A45C2A5Q30471963-88666686-0944-450C-803D-B150D92964C4Q31163228-DD376AA8-DEF3-4FA2-B9D6-692C990ECE84Q33755211-3D94D280-B390-4C14-999F-16789EC962D4Q34087082-D279D686-02D9-47D0-AD29-19C22C8303A8Q34470362-F7395D4E-70CE-41BF-8F5C-7B6BAF2B7041Q34587440-F9B0C4B4-C137-47B5-990D-88FC2FDB78F9Q34971199-3B0D2B0C-9190-4C9B-B45F-D72BAF9214FCQ35072812-D1D16260-119B-4EE9-81C4-9042920CAAA0Q35179053-1D9C5872-3ECC-4A44-B5B5-2B37AF22DA4CQ35913141-4163D413-5D33-4E50-82CB-89E84A2592E6Q35966817-50B24101-0850-4B42-AB00-9B27CFAD030CQ36031101-96FE72B9-76DA-40E1-AE59-04640599786CQ36233320-EB3DA290-4F44-4AFF-8603-33CE1313F1D9Q36266782-05DFED47-C37E-4C3B-91CA-521FC491D16EQ36755908-591B9EB1-FF43-43FD-AEC1-60FA9A2FF823Q37103334-87701BC7-DD36-4610-8623-4ABE9DA07034Q37206280-D731EBAE-1677-41DC-A19C-E0F1104DAAD7Q37515934-197BD850-422C-4E6E-9B91-689A8A157310Q37554913-027B3607-A1FF-466D-B095-66D43D9A5538Q38037141-68A516B7-2109-46A3-B863-BBA50CD7B76FQ38677673-ECA08793-4CE1-4780-9319-6640A8F41EB7Q39015847-5033B67F-DC7F-417A-A39B-F6530E6807D2Q39481120-25C043DF-91D2-4E7F-A99F-C162F6620627Q39674704-D400D5C0-BF53-4392-B9AB-7C3B952AB1D9Q42025447-CB47E6FA-654A-4BAA-BA38-E1865AD95B46Q42434631-5BBCA307-8EF3-43B1-8DF8-DA15142D41CAQ45902720-CE0D3DDA-927A-4DDC-85C1-9ABC8E2181CEQ48143733-A1951F72-6A79-45A0-8436-DDEEEDA9ABEFQ48346007-4FD4CB71-19D3-464E-A82F-1F96A968525AQ54440509-2A4FCA68-6757-4AD6-855D-7ADFAD183F60
P2860
The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The selective 5-HT2A receptor ...... ffects of the SSRI fluoxetine.
@ast
The selective 5-HT2A receptor ...... ffects of the SSRI fluoxetine.
@en
The selective 5-HT2A receptor ...... ffects of the SSRI fluoxetine.
@nl
type
label
The selective 5-HT2A receptor ...... ffects of the SSRI fluoxetine.
@ast
The selective 5-HT2A receptor ...... ffects of the SSRI fluoxetine.
@en
The selective 5-HT2A receptor ...... ffects of the SSRI fluoxetine.
@nl
prefLabel
The selective 5-HT2A receptor ...... ffects of the SSRI fluoxetine.
@ast
The selective 5-HT2A receptor ...... ffects of the SSRI fluoxetine.
@en
The selective 5-HT2A receptor ...... ffects of the SSRI fluoxetine.
@nl
P2093
P2860
P356
P1476
The selective 5-HT2A receptor ...... ffects of the SSRI fluoxetine.
@en
P2093
Allyson Abo
Francesc Artigas
Gerard J Marek
Raul Martin-Ruiz
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300762
P407
P577
2005-12-01T00:00:00Z
P5875
P6179
1033084054